Revision: May 31, 2023, 11:18 a.m.
Rep. Merchant, Sull. 6
Rep. Layon, Rock. 13
Rep. Weber, Ches. 5
May 19, 2023
2023-1954h
05/07
Amendment to SB 240
Amend the bill by replacing section 1 with the following:
1 Conditions of Genetic Testing. RSA 141-H:2, IV is repealed and reenacted to read as follows:
IV.(a) Nothing in this section shall limit genetic testing or genetic analysis used for diagnosis and treatment of a consenting patient by a clinical laboratory that has received a specimen referral from the individual patient's treating physician, genetic counselor, or another clinical laboratory.
(b) This section allows for the disclosure of genetic testing or genetic analysis to entities participating in the clinical care of the patient.
(c) Nothing in this section shall be construed to waive the requirement that the treating physician obtain specific informed patient consent in accordance with the provisions of this section for clinical research.
2023-1954h
AMENDED ANALYSIS
This bill permits disclosure of genetic testing or genetic analysis to clinical entities participating in the clinical care of the patient. The bill clarifies that specific informed consent from the patient is required when such disclosure is made for clinical research purposes.